| Basics |
Myomo Inc.
Myomo Inc is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces.
|
| IPO Date: |
June 12, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$42.34M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 3.91%
|
| Avg Daily Range (30 D): |
$0.05 | 4.59%
|
| Avg Daily Range (90 D): |
$0.06 | 3.81%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.36M |
| Avg Daily Volume (30 D): |
2.02M |
| Avg Daily Volume (90 D): |
1.32M |
| Trade Size |
| Avg Trade Size (Sh.): |
221 |
| Avg Trade Size (Sh.) (30 D): |
370 |
| Avg Trade Size (Sh.) (90 D): |
279 |
| Institutional Trades |
| Total Inst.Trades: |
10 |
| Avg Inst. Trade: |
$1.35M |
| Avg Inst. Trade (30 D): |
$2.55M |
| Avg Inst. Trade (90 D): |
$2.55M |
| Avg Inst. Trade Volume: |
.4M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.81M |
| Avg Closing Trade (30 D): |
$6.14M |
| Avg Closing Trade (90 D): |
$6.14M |
| Avg Closing Volume: |
613.68K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.22
|
$-.11
|
$-.08
|
|
Diluted EPS
|
$-.22
|
$-.11
|
$-.08
|
|
Revenue
|
$ 40.76M
|
$ 9.65M
|
$ 9.83M
|
|
Gross Profit
|
$ 28.22M
|
$ 6.05M
|
$ 6.61M
|
|
Net Income / Loss
|
$ -9.32M
|
$ -4.63M
|
$ -3.47M
|
|
Operating Income / Loss
|
$ -9.31M
|
$ -4.59M
|
$ -3.52M
|
|
Cost of Revenue
|
$ 12.54M
|
$ 3.6M
|
$ 3.22M
|
|
Net Cash Flow
|
$ 8.68M
|
$ -5.62M
|
$ -4.61M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 31, 2020:
1:30
|
|
|
|